Piperazine derivatives and their use as 5-HT1A antagonists

A compound of general formula (A) is described together with pharmaceutically acceptable acid addition salts thereof. The compound is a 5-HT1A antagonist which is useful in the treatment of CNS disorders in mammals.

Saved in:
Bibliographic Details
Main Authors A. FENSOME, M. G. KELLY, H. L. MANSELL
Format Patent
LanguageEnglish
Published 19.08.1998
Edition6
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:A compound of general formula (A) is described together with pharmaceutically acceptable acid addition salts thereof. The compound is a 5-HT1A antagonist which is useful in the treatment of CNS disorders in mammals.
Bibliography:Application Number: CN19961095610